• Nachrichtendetail
• 

26.04.2024 14:21:38 - dpa-AFX: *CHMP BACKS J&J'S RYBREVANT COMBO FOR FIRST-LINE NSCLC WITH EGFR EXON 20 MUTATION

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	JOHNSON + JOHNSON DL 1	853260	Xetra	137,380	26.06.24 13:23:18	-0,780	-0,56%	137,320	137,500	137,940	138,160